What Made the News
in 2009
Study:
Malignant Pheo, Paraganglioma, Metastatic Carcinoid
Molecular Insight Pharmaceuticals, Inc.
conducted and
completed a clinical trial to benefit patients with certain types
of
pheochromocytoma, paraganglioma or metastatic carcinoid tumors.
The Pheo-Para Alliance
announced a 2009 conference to be held in Parsippany, NJ on September 30.
through October 2.
Dr. Karel Pacak was the main
speaker on Pheochromocytoma: An overview of Research Achievements.
For details of
this event and information, please refer to the link directly below.
2009
Pheochromocytoma and Paraganglioma Conference
Pheochromocytoma
Support
Board
